C E Juge-Aubry
Overview
Explore the profile of C E Juge-Aubry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ybarra J, Lehmann T, Golay A, Juge-Aubry C, Roux-Lombard P, Dayer J, et al.
Diabetes Metab
. 2008 Feb;
34(1):75-81.
PMID: 18243027
Unlabelled: Adipose tissue secretes a variety of cytokines, some of which are increased in the serum of obese patients. The anti-inflammatory interleukin-1 receptor antagonist (IL-1Ra) is the most highly elevated...
2.
Juge-Aubry C, Meier C
Journ Annu Diabetol Hotel Dieu
. 2006 Oct;
:129-40.
PMID: 17051856
No abstract available.
3.
De Gottardi A, Pazienza V, Pugnale P, Bruttin F, Rubbia-Brandt L, Juge-Aubry C, et al.
Aliment Pharmacol Ther
. 2006 Jan;
23(1):107-14.
PMID: 16393287
Background: Steatosis in chronic hepatitis C is associated with inflammation and accelerated fibrogenesis. Aim: To assess the contribution of peroxisome proliferator-activated receptor-alpha and -gamma to the pathogenesis of hepatitis C...
4.
Somm E, Cettour-Rose P, Asensio C, Charollais A, Klein M, Theander-Carrillo C, et al.
Diabetologia
. 2005 Dec;
49(2):387-93.
PMID: 16385385
Aims/hypothesis: The IL-1 receptor antagonist (IL-1Ra) is an anti-inflammatory cytokine known to antagonise the actions of IL-1. We have previously shown that IL-1Ra is markedly upregulated in the serum of...
5.
Palmer G, Mezin F, Juge-Aubry C, Plater-Zyberk C, Gabay C, Guerne P
Ann Rheum Dis
. 2003 Dec;
63(1):43-9.
PMID: 14672890
Background: Interferon (IFN) beta displays anti-inflammatory and immunosuppressive activity and has been considered for the treatment of rheumatoid arthritis (RA). Information about the effects of this molecule on joint cells...
6.
Juge-Aubry C, Kuenzli S, Sanchez J, Hochstrasser D, Meier C
Biochem J
. 2001 Jan;
353(Pt 2):253-8.
PMID: 11139388
The transcriptional activity of peroxisome proliferator-activated receptors (PPARs), and of nuclear hormone receptors in general, is subject to modulation by cofactors. However, most currently known co-activating proteins interact in a...
7.
Rebsamen M, Arrighi J, Juge-Aubry C, Vallotton M, Lang U
J Mol Cell Cardiol
. 2000 Apr;
32(4):599-610.
PMID: 10756117
Epidermal growth factor (EGF) was tested for its ability to promote hypertrophic responses in neonatal rat ventricular cardiomyocytes. Exposure of these cells to 100 n m EGF for 2-18 h...
8.
Juge-Aubry C, Hammar E, PERNIN A, Takeshita A, Chin W, Burger A, et al.
J Biol Chem
. 1999 Apr;
274(15):10505-10.
PMID: 10187842
The peroxisome proliferator-activated receptors (PPARs) are a subgroup of nuclear receptors activated by fatty acids and eicosanoids. In addition, they are subject to phosphorylation by insulin, resulting in the activation...
9.
Pauli V, Juge-Aubry C, Boss O, PERNIN A, Chin W, Cusin I, et al.
J Clin Invest
. 1998 Feb;
100(11):2858-64.
PMID: 9389752
Leptin is thought to exert its actions on energy homeostasis through the long form of the leptin receptor (OB-Rb), which is present in the hypothalamus and in certain peripheral organs,...
10.
Liang H, Juge-Aubry C, OConnell M, Burger A
Eur J Endocrinol
. 1997 Dec;
137(5):537-44.
PMID: 9405035
In order to compare the effect of 3,5,3'-triiodothyroacetic acid (TRIAC) with those of triiodothyronine (T3) and thyroxine (T4), severely hypothyroid rats (n=56) were infused over 13 days with 1, 2...